vs

Side-by-side financial comparison of CVD EQUIPMENT CORP (CVV) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $5.0M, roughly 1.4× CVD EQUIPMENT CORP). Lakeside Holding Ltd runs the higher net margin — -22.6% vs -25.6%, a 3.0% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs -33.2%).

CVD Equipment Corp designs, manufactures and supplies custom chemical vapor deposition systems, thermal processing equipment and related process control solutions. Its offerings cater to semiconductor manufacturing, renewable energy, aerospace, and advanced materials research segments, serving commercial and academic customers globally.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

CVV vs LSH — Head-to-Head

Bigger by revenue
LSH
LSH
1.4× larger
LSH
$7.0M
$5.0M
CVV
Growing faster (revenue YoY)
LSH
LSH
+128.3% gap
LSH
95.0%
-33.2%
CVV
Higher net margin
LSH
LSH
3.0% more per $
LSH
-22.6%
-25.6%
CVV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVV
CVV
LSH
LSH
Revenue
$5.0M
$7.0M
Net Profit
$-1.3M
$-1.6M
Gross Margin
22.2%
27.2%
Operating Margin
-27.2%
-21.3%
Net Margin
-25.6%
-22.6%
Revenue YoY
-33.2%
95.0%
Net Profit YoY
-1060.6%
18.7%
EPS (diluted)
$-0.19
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVV
CVV
LSH
LSH
Q4 25
$5.0M
$7.0M
Q3 25
$7.4M
$6.1M
Q2 25
$5.1M
$6.3M
Q1 25
$8.3M
$3.8M
Q4 24
$7.4M
$3.6M
Q3 24
$8.2M
$4.1M
Q2 24
$6.3M
Q1 24
$4.9M
Net Profit
CVV
CVV
LSH
LSH
Q4 25
$-1.3M
$-1.6M
Q3 25
$384.0K
$-1.4M
Q2 25
$-1.1M
$-893.1K
Q1 25
$360.0K
$-1.1M
Q4 24
$132.0K
$-1.9M
Q3 24
$203.0K
$-1.3M
Q2 24
$-761.0K
Q1 24
$-1.5M
Gross Margin
CVV
CVV
LSH
LSH
Q4 25
22.2%
27.2%
Q3 25
32.7%
18.2%
Q2 25
21.0%
26.7%
Q1 25
32.4%
18.8%
Q4 24
26.3%
-1.2%
Q3 24
21.5%
12.8%
Q2 24
24.3%
Q1 24
16.2%
Operating Margin
CVV
CVV
LSH
LSH
Q4 25
-27.2%
-21.3%
Q3 25
4.2%
-20.8%
Q2 25
-22.3%
-8.9%
Q1 25
3.2%
-28.2%
Q4 24
0.4%
-55.6%
Q3 24
0.9%
-32.5%
Q2 24
-14.2%
Q1 24
-33.0%
Net Margin
CVV
CVV
LSH
LSH
Q4 25
-25.6%
-22.6%
Q3 25
5.2%
-22.2%
Q2 25
-20.8%
-14.2%
Q1 25
4.3%
-28.2%
Q4 24
1.8%
-54.1%
Q3 24
2.5%
-32.7%
Q2 24
-12.0%
Q1 24
-29.9%
EPS (diluted)
CVV
CVV
LSH
LSH
Q4 25
$-0.19
$-0.08
Q3 25
$0.06
$-0.09
Q2 25
$-0.15
$-0.11
Q1 25
$0.05
$-0.14
Q4 24
$0.02
$-0.26
Q3 24
$0.03
$-0.18
Q2 24
$-0.11
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVV
CVV
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$8.7M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$24.7M
$12.2M
Total Assets
$27.5M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVV
CVV
LSH
LSH
Q4 25
$8.7M
$1.6M
Q3 25
$8.4M
$4.5M
Q2 25
$7.0M
$5.0M
Q1 25
$10.2M
$1.5M
Q4 24
$12.6M
$1.1M
Q3 24
$10.0M
$2.7M
Q2 24
$10.0M
Q1 24
$11.9M
Total Debt
CVV
CVV
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$268.0K
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
CVV
CVV
LSH
LSH
Q4 25
$24.7M
$12.2M
Q3 25
$25.8M
$7.0M
Q2 25
$25.2M
$2.8M
Q1 25
$26.0M
$749.8K
Q4 24
$25.4M
$1.6M
Q3 24
$25.0M
$3.6M
Q2 24
$24.5M
Q1 24
$25.0M
Total Assets
CVV
CVV
LSH
LSH
Q4 25
$27.5M
$24.3M
Q3 25
$29.8M
$18.6M
Q2 25
$29.9M
$14.4M
Q1 25
$31.1M
$9.9M
Q4 24
$31.7M
$9.8M
Q3 24
$31.8M
$10.8M
Q2 24
$33.8M
Q1 24
$35.4M
Debt / Equity
CVV
CVV
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.01×
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVV
CVV
LSH
LSH
Operating Cash FlowLast quarter
$397.0K
$-453.5K
Free Cash FlowOCF − Capex
$396.0K
FCF MarginFCF / Revenue
8.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVV
CVV
LSH
LSH
Q4 25
$397.0K
$-453.5K
Q3 25
$1.4M
$-4.0M
Q2 25
$-3.2M
$-483.7K
Q1 25
$-2.3M
$-238.3K
Q4 24
$2.3M
$-530.2K
Q3 24
$32.0K
$-1.4M
Q2 24
$-1.7M
Q1 24
$-2.0M
Free Cash Flow
CVV
CVV
LSH
LSH
Q4 25
$396.0K
Q3 25
Q2 25
$-3.2M
$-497.4K
Q1 25
$-2.3M
Q4 24
$2.1M
$-560.5K
Q3 24
$-5.0K
$-1.4M
Q2 24
$-1.8M
Q1 24
$-2.1M
FCF Margin
CVV
CVV
LSH
LSH
Q4 25
8.0%
Q3 25
Q2 25
-62.1%
-7.9%
Q1 25
-27.7%
Q4 24
28.8%
-15.6%
Q3 24
-0.1%
-34.5%
Q2 24
-29.0%
Q1 24
-42.9%
Capex Intensity
CVV
CVV
LSH
LSH
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.1%
0.2%
Q1 25
0.5%
0.0%
Q4 24
1.5%
0.8%
Q3 24
0.5%
0.1%
Q2 24
1.8%
Q1 24
1.4%
Cash Conversion
CVV
CVV
LSH
LSH
Q4 25
Q3 25
3.53×
Q2 25
Q1 25
-6.28×
Q4 24
17.05×
Q3 24
0.16×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVV
CVV

Transferred Over Time$3.8M76%
Transferred At Point In Time$1.2M24%

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons